Addus HomeCare CorporationADUSNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 93% recommend buying.

Consensus Rating

Buy

14 analysts·Moderate coverage

93%

Rating Distribution

Strong Buy

00%

Buy

1393%

Hold

00%

Sell

17%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 28% higher.

Bear Case

$117.00

+13%

Consensus

$132.33

+28%

Bull Case

$145.00

+40%

Price Range14 analysts

Low

Consensus

High

$117.00

$145.00

Current Target

Current Price

$103.48

Upside to Target

$28.85

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$6.86(9 analysts)

P/E22x

Current: 22.2x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+4.72%

EPS+8.68%

FY2028

Rev+5.20%

EPS+9.26%

Earnings Surprises

Beat rate:100%(12/12 quarters)

Avg surprise:+7.5%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 7, 2026Truist Financial

Addus HomeCare initiated with a Buy at Truist

Target:$135.00

+21.6%from $110.98

Nov 4, 2025Barclays

Addus HomeCare price target raised to $117 from $111 at Barclays

Target:$117.00

-1.7%from $118.99

Sep 2, 2025UBS

Addus HomeCare initiated with a Buy at UBS

Target:$145.00

+25.4%from $115.67

Dec 16, 2024JMP Securities

Addus HomeCare initiated with an Outperform at JMP Securities

Target:$150.00

+22.0%from $122.95

Nov 6, 2024Stephens

Addus HomeCare (ADUS) PT Raised to $145 at Stephens

Target:$145.00

+16.3%from $124.67

Oct 10, 2024KeyBanc

Addus HomeCare initiated with an Overweight at KeyBanc

Target:$150.00

+17.7%from $127.44

Sep 23, 2024Oppenheimer

Addus HomeCare (ADUS) PT Raised to $145 at Oppenheimer

Target:$145.00

+10.4%from $131.35

Aug 8, 2024RBC Capital

Addus HomeCare (ADUS) PT Raised to $141 at RBC Capital

Target:$141.00

+15.4%from $122.22

Aug 7, 2024Oppenheimer

Addus HomeCare (ADUS) PT Raised to $140 at Oppenheimer

Target:$140.00

+14.5%from $122.22

Jun 7, 2024Oppenheimer

Addus HomeCare (ADUS) PT Raised to $130 at Oppenheimer

Target:$130.00

+12.0%from $116.07

May 31, 2024Stephens

Addus HomeCare (ADUS) PT Raised to $128 at Stephens

Target:$128.00

+14.6%from $111.73

May 28, 2024RBC Capital

Addus HomeCare (ADUS) PT Raised to $129 at RBC Capital

Target:$129.00

+15.6%from $111.61

Apr 23, 2024Barclays

Barclays downgrades Addus to Underweight on 'materially negative' regulation

Target:$83.00

-10.9%from $93.14

Apr 1, 2024Stephens

Addus HomeCare price target raised to $115 from $110 at Stephens

Target:$115.00

+11.3%from $103.34

Jun 29, 2022Stephens

Addus HomeCare (ADUS) Stock: $101 Target And Overweight Rating

Target:$101.00

+18.6%from $85.14

May 4, 2022RBC Capital

RBC Capital Maintains Outperform on Addus HomeCare, Lowers Price Target to $111

Target:$111.00

+34.8%from $82.34

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance